Q2 2024 Earnings Call Transcript November 12, 2024 Operator: Good day and thank you for standing by. Welcome to the Roivant ...

ZUG, Switzerland, Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ ...

Present in Vietnam since 1994, Bayer has steadfastly pursued its mission “Health for All, Hunger for None”, fostering ...

Diabetes is a chronic condition where the body either cannot produce enough insulin (Type 1) or struggles to use it ...

Boehringer Ingelheim and MTM Vision join forces to combat vision loss from diabetes: Ingelheim, Germany Wednesday, November 13, 2024, 10:00 Hrs [IST] Boehringer Ingelheim and the ...

Good day and thank you for standing by. Welcome to the Roivant second-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I ...

Gross profit for the third quarter of 2024 was $4.3 million, or a 37.3% gross margin, a decrease compared to $5.6 million, or a 43.7% gross margin, in the same period of the prior year. This decrease ...

One of the complications of DR is Diabetic macular edema (DME). DME can occur at any stage of diabetic retinopathy, although ...

About diabetic retinal disease Diabetic retinal disease (DRD) includes all diabetes-related changes in the retina, including ...